DO, IT, Manufacturing and Patients

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Manufacturing

Patients

Patients Preferences and Difficulties with 5 Different Fecal Immunochemical Tests (FITs) [Screening, prevention, and health promotion]

Annals of Family Medicine

NOVEMBER 20, 2024

Context: FITs are an accepted method of colorectal cancer (CRC) screening and patients’ preferences and difficulties are unknown. FIT manufacturers should develop very clear directions for patients. FITs would save nearly as many lives as colonoscopy with far fewer complications. Multiple FITs are available in the U.S.

Screening

Screening Patients Individual Patient-Centered

Biased research, aggressive sales, harmful drugs

The Health Policy Exchange

MAY 20, 2013

Food and Drug Administration to market a new drug is a critical waypoint along the path to profits for pharmaceutical manufacturers. Very quickly, the market included nearly all dialysis patients, not just the roughly 16 percent who required blood transfusions. Approval from the U.S. The size of average doses would more than triple.

Manufacturing

Manufacturing Family Medicine DO Government

Primary Care Digest

Patients Preferences and Difficulties with 5 Different Fecal Immunochemical Tests (FITs) [Screening, prevention, and health promotion]

Biased research, aggressive sales, harmful drugs

Stay Connected